Analysis from the Women's Health Initiative has found that women who took the bone saving drugs called bisphosphonates had fewer invasive breast cancers than women who didn't take the meds. The analysis of more than 150,000 women found that those who were taking Fosamax had 32 percent fewer cases of invasive breast cancer. Experts say further studies are needed, but they suggest that the finding may affect a woman's decision about whether she takes a bisphosphonate or not.
An experimental compound called MK-0752 appears to be successful at killing breast cancer stem cells, researchers say. These stem cells are important... Read more »
The osteoporosis med Evista may help prevent certain kinds of breast cancer, a new study suggests. The drug is already approved for women who are at... Read more »
Canadian scientists say that meds developed to treat diabetes and obesity may also fight breast cancer. The medications were originally developed to... Read more »
New research published in the journal Anesthesia & Analgesia suggests that the type of painkiller a woman uses after undergoing a mastectomy may... Read more »
The experimental breast cancer drug Iniparib appears to shrink tumors, increase the time tumors take to progress, and prolongs survival in women with... Read more »